Trial Information

Summary: Investigational monoclonal antibody study for People with Type 1 Diabetes Mellitus

People between the ages of 18 and 60 with Type 1 Diabetes Mellitus are needed to participate in a research study of an investigational monoclonal antibody. There is no charge for study visits. Most study visits take place over a 12 week period with periodic follow-up for 4 years. Qualified participants may be compensated for time and travel required.

Study inclusion / exclusion criteria

Men or Women of any race between 18-60 years old who are generally in good health and with a history of Type 1 Diabetes Mellitus; must be willing come to the clinic for 8 sequential days of dosing; any existing medications must be on a stable dose for 4 weeks. Multiple blood draws will be required throughout this study. Interested patients must give informed consent and be willing to be evaluated via a physical examination and several laboratory tests prior to being allowed to participate. People with a prior history of HIV, tuberculosis, syphilis, hepatitis, spleen removal, severe allergic reactions, or alcohol or drug dependency or abuse are not permitted to participate in the study.

Central Contact Info:

Telephone: 1-877-515-6672
Email: clinicaltrials@tolerx.com

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:30:25 AM